These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24744135)

  • 1. Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.
    Kitajima K; Ebina Y; Sugimura K
    Jpn J Radiol; 2014 Jun; 32(6):313-23. PubMed ID: 24744135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
    Kitajima K; Suenaga Y; Sugimura K
    Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established, emerging and future applications of FDG-PET/CT in the uterine cancer.
    Kitajima K; Murakami K; Kaji Y; Sakamoto S; Sugimura K
    Clin Radiol; 2011 Apr; 66(4):297-307. PubMed ID: 21356392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
    Kitajima K; Miyoshi Y
    Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
    Donswijk ML; Hess S; Mulders T; Lam MG
    PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-
    Kalshetty A; Basu S
    PET Clin; 2018 Apr; 13(2):239-248. PubMed ID: 29482752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET/CT: whither I go, thou canst not follow me now; but thou shalt follow me afterwards.
    Hess S; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):xi-xiii. PubMed ID: 25455884
    [No Abstract]   [Full Text] [Related]  

  • 8. Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update.
    Kitajima K; Nakajo M; Kaida H; Minamimoto R; Hirata K; Tsurusaki M; Doi H; Ueno Y; Sofue K; Tamaki Y; Yamakado K
    Nagoya J Med Sci; 2017 Nov; 79(4):527-543. PubMed ID: 29238109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies.
    Gorospe L; Jover-Díaz R; Vicente-Bártulos A
    Abdom Imaging; 2012 Dec; 37(6):1041-65. PubMed ID: 22349805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future of FDG-PET/CT in ovarian cancer.
    Kitajima K; Murakami K; Sakamoto S; Kaji Y; Sugimura K
    Ann Nucl Med; 2011 Apr; 25(3):155-64. PubMed ID: 21113691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's New in Imaging for Gynecologic Cancer?
    Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
    Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary experience with 18f-fluoro-deoxy-glucose positron emission tomography/computed tomography in pediatric oncology patients.
    Odalović S; Sobić-Saranović D; Pavlović S; Grozdić I; Saranović D; Petrović M; Milovanović A; Petrasinović Z; Djurić-Stefanović A; Obradović V
    Acta Chir Iugosl; 2011; 58(4):67-73. PubMed ID: 22519195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET-CT of gynecologic cancers: pearls and pitfalls.
    Prabhakar HB; Kraeft JJ; Schorge JO; Scott JA; Lee SI
    Abdom Imaging; 2015 Oct; 40(7):2472-85. PubMed ID: 25680500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG PET/CT in oncology: "raising the bar".
    Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of FDG-PET/CT in gynaecological cancers.
    Rockall AG; Cross S; Flanagan S; Moore E; Avril N
    Cancer Imaging; 2012 Mar; 12(1):49-65. PubMed ID: 22391444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present and future of PET and PET/CT in gynaecologic malignancies.
    Musto A; Rampin L; Nanni C; Marzola MC; Fanti S; Rubello D
    Eur J Radiol; 2011 Apr; 78(1):12-20. PubMed ID: 20116952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pivotal role of FDG-PET/CT in modern medicine.
    Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
    Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [¹⁸F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography imaging in oncology: initial staging and evaluation of cancer therapy.
    Pauwels EK; Coumou AW; Kostkiewicz M; Kairemo K
    Med Princ Pract; 2013; 22(5):427-37. PubMed ID: 23363934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.